Skip header and navigation

Refine By

38 records – page 1 of 4.

[Analysis of the results of epidemiological study on prevalence of erectile dysfunction in the Russian Federation].

https://arctichealth.org/en/permalink/ahliterature116608
Source
Urologiia. 2012 Sep-Oct;(6):5-9
Publication Type
Article
Author
D Iu Pushkar'
A A Kamalov
S Kh Al'-Shukri
A A Erkovich
M I Kogan
V N Pavlov
V N Zhuravlev
A N Bernikov
Source
Urologiia. 2012 Sep-Oct;(6):5-9
Language
Russian
Publication Type
Article
Keywords
Adult
Age Factors
Aged
Erectile Dysfunction - epidemiology
Humans
Male
Middle Aged
Prevalence
Questionnaires
Russia - epidemiology
Abstract
With the aim of evaluation of prevalence of erectile dysfunction (ED) and other violations of the sexual function of men in the Russian Federation, anonymous questionnaire survey of 1400 men was performed. The study involved seven centers located in the most densely populated regions of the country. 1225 questionnaires were analyzed. It was found that ED symptoms were present in 1101 (89.9%) respondents. Age-related symptoms (by AMS questionnaire) were detected in 554 (45.2%) patients, most of whom were aged 45-59 years. The importance of active detection of ED in men, as it can be one of manifestation of a more serious disease, was demonstrated.
PubMed ID
23379231 View in PubMed
Less detail

Can sexual bother after radical prostatectomy be predicted preoperatively? Findings from a prospective national study of the relation between sexual function, activity and bother.

https://arctichealth.org/en/permalink/ahliterature130470
Source
BJU Int. 2012 May;109(9):1366-74
Publication Type
Article
Date
May-2012
Author
Eivind A S Steinsvik
Karol Axcrona
Alv A Dahl
Lars M Eri
Andreas Stensvold
Sophie D Fosså
Author Affiliation
National Resource Center for Late Effects, Oslo University Hospital, Oslo, Norway. steinsviks@gmail.com
Source
BJU Int. 2012 May;109(9):1366-74
Date
May-2012
Language
English
Publication Type
Article
Keywords
Aged
Erectile Dysfunction - epidemiology - etiology
Humans
Male
Middle Aged
Norway - epidemiology
Postoperative Complications - epidemiology
Prognosis
Prospective Studies
Prostatectomy - adverse effects
Risk factors
Sexual Behavior - physiology
Abstract
What's known on the subject? And what does the study add? Sexual function is often impaired after radical prostatectomy resulting in reduced sexual activity and sexual bother. The main focus in the literature concerning sexual adverse effects has been on erectile dysfunction and impairment of sexual function rather than the actual sexual bother it causes, although the sexual bother is most important to the individual patient's quality of life. The relation between these measures, and in particular preoperative prediction of postoperative sexual bother, has only been studied in a limited way and with varying results. Some studies have found good mental health, low levels of preoperative sexual bother, and higher education to be associated with absence of postoperative sexual bother, but another study could not identify any preoperative predictors of postoperative sexual bother. Severe sexual bother after radical prostatectomy was reported by 64% to 95% of patients 3 years after operation, and the prevalence was associated with the level of pretreatment sexual bother and peroperative nerve preservation. On the other hand, others have reported that only 43% of men have sexual bother 2 years after radical prostatectomy. However, none of these studies stratified patients according to their preoperative sexual activity and most of them were American. It has been shown that American findings concerning sexual bother may not always be valid for non-American patients due to differing sex role expectations, thus warranting the need for more non-American studies. This study has shown that two-thirds of patients experienced sexual bother 1 year after radical prostatectomy. We have identified patients with increased risk of experiencing overall sexual bother postoperatively: those who report preoperative sexual bother, those who are sexually active before radical prostatectomy, and those who display neurotic personality traits. Another important finding is that the proportion of patients who experienced bother relevant to having impaired postoperative sexual function was significantly higher among preoperatively sexually active patients than those who had been inactive. This study adds knowledge that patients' preoperative sexual activity, sexual bother and personality should be taken into account to be able to give individualized information about the risk of experiencing sexual bother after radical prostatectomy. Study Type--Therapy (outcomes research). Level of Evidence 2c.
â?¢ To explore the prevalence and prediction of overall sexual bother (SB) 1 year after radical prostatectomy (RP) in relation to preoperative sexual activity and postoperative sexual function.
â?¢ This prospective national study included 453 men who completed the sexual domain of the Expanded Prostate Cancer Index Composite before and 1 year after RP. â?¢ Preoperatively the patients were classified as sexually active or inactive based on frequency of intercourse during the previous 4 weeks. â?¢ The prevalence of 1-year SB and the proportion of bothered patients with impaired sexual function were calculated. â?¢ Preoperative factors significantly associated with postoperative SB on univariate analysis (P
Notes
Comment In: J Urol. 2012 Jun;187(6):216822579197
PubMed ID
21999333 View in PubMed
Less detail

Carpal tunnel syndrome in patients with diabetic polyneuropathy.

https://arctichealth.org/en/permalink/ahliterature191211
Source
Diabetes Care. 2002 Mar;25(3):565-9
Publication Type
Article
Date
Mar-2002
Author
Bruce A Perkins
David Olaleye
Vera Bril
Author Affiliation
Beth Israel Deaconness Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Source
Diabetes Care. 2002 Mar;25(3):565-9
Date
Mar-2002
Language
English
Publication Type
Article
Keywords
Adult
Carpal Tunnel Syndrome - epidemiology
Cohort Studies
Diabetic Foot - epidemiology
Diabetic Nephropathies - epidemiology
Diabetic Neuropathies - epidemiology
Erectile Dysfunction - epidemiology
Female
Hemoglobin A, Glycosylated - analysis
Humans
Hypotension, Orthostatic - epidemiology
Male
Middle Aged
Ontario - epidemiology
Prevalence
Reference Values
Regression Analysis
Sensory Receptor Cells - physiology - physiopathology
Abstract
Carpal tunnel syndrome (CTS) and diabetic polyneuropathy (DPN) are common conditions in patients with diabetes and therefore frequently occur concomitantly. Diagnosis of CTS in patients with DPN is important, as therapeutic interventions directed toward relief of CTS may be effective irrespective of diffuse neuropathy. The prevalence of clinical CTS and the most efficient electrodiagnostic discriminators of CTS from diffuse neuropathy are uncertain.
A total of 478 subjects, including reference subjects (without diabetes and without neuropathy), nonneuropathic subjects with diabetes, and diabetic subjects with mild, moderate, and severe neuropathy, were evaluated in a cross-sectional design for clinical features of CTS. In the ascertainment of the cohort, a clinical stratification method was used to ensure a broad spectrum of neuropathy severity. All subjects underwent nerve conduction study determinations of median, ulnar, and sural nerve parameters.
The prevalence of clinical CTS was 2% in the reference population, 14% in diabetic subjects without DPN, and 30% in those with DPN. Multiple linear regression analysis revealed that mean electrodiagnostic parameters are not significant predictors of clinical CTS in patients with diabetes. Generally, the parameters worsened with severity of neuropathy, but none reliably distinguished diabetic patients with and without CTS.
Given the high prevalence of CTS in patients with DPN and that electrodiagnostic criteria cannot distinguish those with clinical CTS, it is recommended that therapeutic decisions for CTS be made independently of electrodiagnostic findings.
Notes
Comment In: Diabetes Care. 2002 Dec;25(12):2362; author reply 2362-312453995
PubMed ID
11874948 View in PubMed
Less detail

[Clinical outcome of intermediate risk prostate cancer treated with iodine 125 monotherapy: The Hotel-Dieu of Quebec experience].

https://arctichealth.org/en/permalink/ahliterature144012
Source
Cancer Radiother. 2010 Jun;14(3):183-8
Publication Type
Article
Date
Jun-2010
Author
O. Zebentout
R. Apardian
L. Beaulieu
F. Harel
A G Martin
E. Vigneault
Author Affiliation
Département de radiothérapie, CHUQ Hôtel-Dieu, Côte-du-Palais, QC, Canada.
Source
Cancer Radiother. 2010 Jun;14(3):183-8
Date
Jun-2010
Language
French
Publication Type
Article
Keywords
Adenocarcinoma - blood - drug therapy - pathology - radiotherapy
Aged
Antineoplastic Agents, Hormonal - therapeutic use
Brachytherapy - adverse effects - methods
Combined Modality Therapy
Disease-Free Survival
Erectile Dysfunction - epidemiology - etiology
Follow-Up Studies
Humans
Iodine Radioisotopes - administration & dosage - adverse effects - therapeutic use
Male
Middle Aged
Prostate-Specific Antigen - blood
Prostatic Neoplasms - blood - drug therapy - pathology - radiotherapy
Quebec - epidemiology
Radiation Injuries - epidemiology - etiology
Retrospective Studies
Risk
Treatment Outcome
Urination Disorders - epidemiology - etiology
Abstract
To describe the biochemical failure-free survival (BFFS), GU toxicity and erectile dysfunction in intermediate risk prostate cancer treated with iodine 125 monotherapy (I125).
Between October 1994 and October 2007, 1282 patients were treated with I125 at the Hotel Dieu de Quebec. Two hundred patients were intermediate risk prostate cancer. One hundred and fifty-seven had enough follow-up to be evaluated in this study. Biochemical failure-free survival is reported using Phoenix definition. Acute and late GU toxicity was described using the International Prostate Symptoms Score (IPSS) as well as with the rate of bladder catheter. Erectile dysfunction was also reported.
The mean age of the patients was 65.6 years (S.D.=6 years) and the mean pretreatment PSA was 8.7ng/ml. About half of the patients (51%) were T2b/T2c. About 44.6% had a PSA greater than 10 and 4.5% had Gleason score of 7/10. More than half of the patients received a short course of hormones of less than 6 months for cytoreduction (57.4%). The median follow-up was 60 months. Biochemical failure-free survival at 60-month and 96-month were 87.1% and 81% according to Phoenix definition. The mean IPSS rose from 5 immediately after the implant to 15 1 month after and then slowly decreased to 8 at 24 months. Acute urinary retention with bladder catheter occurred in 10.9% of patients. Only 4.3% presented erectile dysfunction at 5 months post-implant.
I125 monotherapy for intermediate risk prostate implant gives biochemical failure-free survivals at 5 years and 8 years comparable to those obtained with high dose external beam radiotherapy. GU toxicity and erectile dysfunction were low and acceptable. Therefore, the use of I125 alone in this group of patients could be presented and discussed with the patient in the waiting of phase III validation.
PubMed ID
20418145 View in PubMed
Less detail

Correlation between pouch function and sexual function in patients with IPAA.

https://arctichealth.org/en/permalink/ahliterature275590
Source
Scand J Gastroenterol. 2016 Mar;51(3):295-303
Publication Type
Article
Date
Mar-2016
Author
Marie Louise Sunde
Tom Øresland
Arne Engebreth Færden
Source
Scand J Gastroenterol. 2016 Mar;51(3):295-303
Date
Mar-2016
Language
English
Publication Type
Article
Keywords
Adenomatous Polyposis Coli - surgery
Adult
Aged
Case-Control Studies
Colitis, Ulcerative - surgery
Colonic Pouches - adverse effects - physiology
Dyspareunia - epidemiology
Erectile Dysfunction - epidemiology
Fecal Incontinence - epidemiology - etiology - psychology
Female
Humans
Male
Middle Aged
Norway - epidemiology
Orgasm - physiology
Proctocolectomy, Restorative
Sexuality - physiology - psychology
Surveys and Questionnaires
Young Adult
Abstract
Restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) is the treatment of choice for ulcerative colitis refractory to medical treatment and familial adenomatous polyposis. The objective of this study was to study the impact of postoperative pouch function on sexual function. Sexual function after IPAA surgery has also been compared to sexual function in the average Norwegian population.
All patients having undergone IPAA from 2000 to June 2013 were identified from the hospital medical record files and sent validated questionnaires regarding their sexual function. Pouch function was scored according to Oresland score through a phone interview. Patients operated on or before June 2012 were asked to answer the same questionnaires twice with an interval of one year to see how stable sexual function is over time.
Sixty-eight out of 100 consecutive patients answered the questionnaire regarding both sexual function and pouch function (44 men, 24 women). There was no significant relationship between pouch and sexual function in men (p-value 0.158, corr. coefficient - 0.216). In women there was a significant relationship (p-value - 0.01, corr. coefficient 0.517). There was no significant shift in sexual function during the study period.
We found no significant correlation between sexual function and pouch function in men. In women, we found a significant correlation between poor pouch function and impaired sexual function. As similar studies have found, sexual function remains good after IPAA surgery. This is an important information for patients and physicians, both to inform patients correctly prior to surgery, and in the postoperative follow-up.
PubMed ID
26452460 View in PubMed
Less detail

[Determinants of risk of the development of erectile dysfunction in the Russian Federation: analysis of epidemiological studies].

https://arctichealth.org/en/permalink/ahliterature256681
Source
Urologiia. 2014 May-Jun;(3):26-31
Publication Type
Article
Author
I A Korneev
T A Alekseeva
S Kh Al'-Shukri
A N Bernikov
A A Erkovich
V N Zhuravlev
A A Kamalov
M I Kogan
V N Pavlov
D Iu Pushkar'
Source
Urologiia. 2014 May-Jun;(3):26-31
Language
Russian
Publication Type
Article
Keywords
Adult
Aged
Erectile Dysfunction - epidemiology - etiology - physiopathology
Humans
Hypertension - complications - epidemiology - physiopathology
Male
Middle Aged
Risk factors
Russia - epidemiology
Abstract
According to the results of epidemiological studies of prevalence of erectile dysfunction in the Russian Federation, the search for the determinants of risk of its development was performed. It was found that the leading risk factors for the development of erectile dysfunction, in descending order of statistical significance, include the amount of accumulation of points according to the IPSS score, arterial hypertension, L(IPSS) quality of life index, age, diabetes, and overweight and obesity.
PubMed ID
25211923 View in PubMed
Less detail

Diabetic cystopathy: epidemiology and related disorders.

https://arctichealth.org/en/permalink/ahliterature246115
Source
Ann Intern Med. 1980 Feb;92(2 Pt 2):318-21
Publication Type
Article
Date
Feb-1980
Author
C. Frimodt-Møller
Source
Ann Intern Med. 1980 Feb;92(2 Pt 2):318-21
Date
Feb-1980
Language
English
Publication Type
Article
Keywords
Adult
Age Factors
Diabetic Nephropathies - epidemiology
Diabetic Neuropathies - epidemiology
Erectile Dysfunction - epidemiology
Female
Humans
Male
Middle Aged
Scandinavia
Sex Factors
Urinary Bladder, Neurogenic - epidemiology - etiology
Urinary Tract Infections - epidemiology
Abstract
The precise incidence and prevalence of diabetic cystopathy are difficult to determine because of the insidious onset, discrete symptoms, and differences in the definition of bladder dysfunction. Diabetic cystopathy, classified according to urophysiological criteria, was shown to occur in 43% to 87% of insulin-dependent diabetics, with no sex or age differences. Another study showed an average 25% prevalence of diabetic cystopathy in patients on oral hypoglycemic treatment. A Scandinavian study showed that in patients who have had diabetes for 10 years, the prevalence of diabetic cystopathy in those who were insulin-dependent was two to four per 1000 and in those on oral hypoglycemic agents was one to three per 1000. The correlation between diabetic cystopathy and peripheral neuropathy ranged from 75% to 100%. Nephropathy was seen in 30% to 40% of cases. The higher frequency of urinary tract infections in diabetics is not related to diabetic cystopathy but to the frequent occurrence of non-neurogenic bladder outlet disorders, especially in older women.
PubMed ID
7356221 View in PubMed
Less detail

Effect of chronic diseases on incidence of erectile dysfunction.

https://arctichealth.org/en/permalink/ahliterature182466
Source
Urology. 2003 Dec;62(6):1097-102
Publication Type
Article
Date
Dec-2003
Author
Rahman Shiri
Juha Koskimäki
Matti Hakama
Jukka Häkkinen
Teuvo L J Tammela
Heini Huhtala
Anssi Auvinen
Author Affiliation
University of Tampere School of Public Health, Tampere, Finland.
Source
Urology. 2003 Dec;62(6):1097-102
Date
Dec-2003
Language
English
Publication Type
Article
Keywords
Age Distribution
Aged
Arthritis - epidemiology
Cardiovascular Diseases - epidemiology
Chronic Disease - epidemiology
Comorbidity
Diabetes Complications
Diabetes Mellitus - epidemiology
Erectile Dysfunction - epidemiology - etiology
Finland - epidemiology
Follow-Up Studies
Humans
Incidence
Lung Diseases - epidemiology
Male
Middle Aged
Questionnaires
Severity of Illness Index
Abstract
To estimate the incidence of erectile dysfunction (ED) in a population-based sample during 5 years' follow-up and determine how the rate was affected by age and medical conditions.
The target population comprised all men aged 50, 60, or 70 years residing in the study area at the time the study began. Questionnaires were mailed to 3143 men in 1994 and to 2864 men in 1999. The follow-up sample consisted of the 1442 men who responded to both the baseline and the follow-up questionnaires. ED was assessed by two questions concerning the subject's ability to achieve and maintain an erection sufficient for intercourse. We estimated the incidence of minimal ED among the 391 men free of ED, of moderate ED in the 1130 with no or minimal ED, and of complete ED among the 1323 men free of complete ED at baseline.
The incidence of minimal ED was 127 cases per 1000 person-years (95% confidence interval 110 to 148). For moderate ED, it was 41 (95% confidence interval 36 to 47) and for complete ED, it was 18 (95% confidence interval 15 to 22). The incidence of minimal ED increased 40% and moderate ED 80% with each decade increment in age; the incidence of complete ED increased 190%. The incidence of ED was increased in men with diabetes (rate ratio 2.4 for minimal, 2.6 for moderate, and 3.4 for complete ED). Hypertension, heart disease, arthritis, pulmonary disease, and cerebrovascular disease had little or no effect on the incidence of ED.
ED is a commonly occurring disorder that increases in incidence strongly between 50 and 75 years of age. Diabetes is a major determinant of ED, but hypertension, heart disease, arthritis, and cerebrovascular disease increase the incidence of ED only marginally.
PubMed ID
14665363 View in PubMed
Less detail

Effect of erectile dysfunction on frequency of intercourse: a population based prevalence study in Finland.

https://arctichealth.org/en/permalink/ahliterature197918
Source
J Urol. 2000 Aug;164(2):367-70
Publication Type
Article
Date
Aug-2000
Author
J. Koskimäki
M. Hakama
H. Huhtala
T L Tammela
Author Affiliation
Division of Urology, Tampere University Hospital, Tampere, Finland.
Source
J Urol. 2000 Aug;164(2):367-70
Date
Aug-2000
Language
English
Publication Type
Article
Keywords
Aged
Coitus
Cross-Sectional Studies
Erectile Dysfunction - epidemiology
Finland - epidemiology
Humans
Male
Marital status
Middle Aged
Questionnaires
Abstract
We estimate the prevalence of erectile dysfunction in Finland and its effect on frequency of sexual intercourse.
A population based study of 3,143, 50, 60 and 70-year-old men in Tampere and 11 municipalities in the same county was conducted by mailed questionnaire. The definition of erectile dysfunction was based on difficulties in achieving an erection before sexual intercourse and maintaining it. Erectile dysfunction was classified into 4 groups as none, minimal, moderate and complete. To estimate the effect of erectile dysfunction on the frequency of sexual intercourse the men were divided into those who had intercourse at least an average of once weekly and those who did not.
A total of 2,198 questionnaires (70%) were returned and 1, 983 men (63%) were included in the study. Of these men 26% had no, 48% minimal, 14% and 12% complete erectile dysfunction, which increased with age (compared with 50-year-old men, the odds ratios for complete erectile dysfunction were 4.5 (95% confidence interval [CI] 2.6-7.5) for 60 and 21 (95% CI 12.5 to 34.7) to 70-year-old men. The effect of erectile dysfunction on the frequency of sexual intercourse could not be accounted for by age or marital status. The adjusted effect was strong among men with moderate (odds ratio 3.5, 95% CI 2.2-5.1) and complete (173, 68-443) erectile dysfunction but minimal erectile dysfunction had no impact (odds ratio 0.9, 95% CI 0. 6-1.3) on the frequency of intercourse.
Erectile difficulties are common and complete erectile dysfunction increases with age. Erectile dysfunction regulates the sex life of men with moderate or complete dysfunction but this association cannot be accounted for by age or marital status. Although mild erectile dysfunction did not completely regulate sex life, its significance is the risk of progression to a more severe sexual life disturbing dysfunction.
PubMed ID
10893587 View in PubMed
Less detail

Effect of life-style factors on incidence of erectile dysfunction.

https://arctichealth.org/en/permalink/ahliterature181283
Source
Int J Impot Res. 2004 Oct;16(5):389-94
Publication Type
Article
Date
Oct-2004
Author
R. Shiri
J. Koskimäki
M. Hakama
J. Häkkinen
H. Huhtala
T L J Tammela
A. Auvinen
Author Affiliation
Tampere School of Public Health, University of Tampere, Tampere, Finland. rahman.shiri@uta.fi
Source
Int J Impot Res. 2004 Oct;16(5):389-94
Date
Oct-2004
Language
English
Publication Type
Article
Keywords
Aged
Aging - physiology
Alcohol drinking - epidemiology
Body mass index
Coffee
Erectile Dysfunction - epidemiology
Finland - epidemiology
Health Surveys
Humans
Life Style
Male
Marriage
Middle Aged
Questionnaires
Rural Population
Smoking - epidemiology
Socioeconomic Factors
Urban Population
Abstract
We estimated the incidence of erectile dysfunction (ED) in a population-based sample during 5-y follow-up and determined how the rate was affected by sociodemographic and life-style factors. The target population comprised all men aged 50, 60 or 70 y residing in the city of Tampere or 11 surrounding municipalities in Finland at the start of follow-up. A questionnaire was mailed to 3143 men in 1994 and to 2864 in 1999. The follow-up sample consisted of 1442 men who responded to both baseline and follow-up questionnaires. We estimated the effect of sociodemographic and life-style factors on the incidence of ED among the 1130 men free of ED at baseline. We found no differences in the incidence of ED by the level of education, marital status, urban/rural place of residence, amount of alcohol and coffee consumption. Obesity (rate ratio (RR)=1.7, 95% confidence interval (CI): 1.1-2.5) and current smoking (RR=1.5, 95% CI: 0.9-2.2) increased the incidence of ED. Current smokers free of comorbidity were also at higher risk of ED (RR=1.3, 95% CI: 0.8-2.1), but no effect was observed among past smokers. Our results indicate that sociodemographic and life-style factors, except age and obesity, have little influence on ED.
PubMed ID
14999220 View in PubMed
Less detail

38 records – page 1 of 4.